Erik A L Biessen

8PUBLICATIONS
57CO-AUTHORS
Cardiology (incl. cardiovascular diseases)HaematologyNanotoxicology, health and safetyGlycoconjugatesGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jan 29, 2026
Whole-Body Knockout of the AhR (Aryl Hydrocarbon Receptor) Ameliorates Atherosclerosis Due to Altered Lipid Metabolism-Brief Report.

Rosanna Huchzermeier, Renske J de Jong, Leonida Rakateli

|Dec 30, 2025
Nonhematopoietic MicroRNA-26b-/- Augments Atherosclerosis Development by Increasing Endothelial Inflammation and Leukocyte Adhesion-Brief Report.

Linsey J F Peters, Kiril Bidzhekov, Remco T A Megens

|May 10, 2023
Monocyte heterogeneity in cardiovascular disease.

Adele V Ruder, Suzan M W Wetzels, Lieve Temmerman

|Jan 31, 2023
Human and murine fibroblast single-cell transcriptomics reveals fibroblast clusters are differentially affected by ageing and serum cholesterol.

Kim van Kuijk, Ian R McCracken, Renée J H A Tillie

|Mar 24, 2022
Magnetic resonance imaging contrast-enhancement with superparamagnetic iron oxide nanoparticles amplifies macrophage foam cell apoptosis in human and murine atherosclerosis.

Filip M E Segers, Adele V Ruder, Marijke M Westra

|Oct 14, 2021
N-Acetyl Galactosamine Targeting: Paving the Way for Clinical Application of Nucleotide Medicines in Cardiovascular Diseases.

Erik A L Biessen, Theo J C Van Berkel

Pageof 2

Frequent Collaborators

4 joint publications

Judith C Sluimer

3 joint publications

Han Jin

3 joint publications

Pieter Goossens

3 joint publications

Barend M E Mees